Henderson, Mark
- National Center for Advancing Translational Sciences (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,365
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.1M
Full award amounts, FY2023
Award Records
13
Records listing this PI
Award-Linked Rank
#3,365
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Henderson, Mark as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000063-09ZIAContact PIModulators of Secreted ER Ca2+ Monitoring Protein (SERCaMP)$310.1Kaward amount
- 1ZIATR000404-04ZIAContact PIHigh-throughput screening to identify modulators of PKD2 function$240.8Kaward amount
- 1ZIATR000405-04ZIAContact PIHigh-throughput screening to identify inhibitors of breast-to-brain metastasis$240.8Kaward amount
- 1ZIATR000428-04ZIAContact PIAMPK synthetic activators$240.8Kaward amount
- 1ZIATR000451-02ZIAContact PIIdentification of small molecule degraders of XPB for inflammatory diseases$125.8Kaward amount
- 1ZIATR000452-02ZIAContact PICharacterizing molecular interactomes using TurboID$125.8Kaward amount
- 1ZIATR000454-02ZIAContact PINew approaches for facilitating transcytosis of biologically active molecules$125.8Kaward amount
- 1ZIATR000466-01ZIAContact PIIdentifying LC3 binders to develop lysosome-targeting chimeras$125.8Kaward amount
- 1ZIATR000449-02ZIAContact PIIdentifying small molecules with selective toxicity towards muscle invasive prostate cancer cells$125.8Kaward amount
- 1ZIATR000432-03ZIAContact PIEvaluation of cAbl allosteric inhibitors in Gaucher-Parkinson$125.8Kaward amount
+3 more grants not shown.
Award organization
Organizations that administered FY2023 awards listing Henderson, Mark as a PI.
FY2023 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardNational Center for Advancing Translational Sciences
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #4344
- 2021Entered Top 25% NationallyRanked #4344
- 2022$2M Cumulative Funding
- 2022Entered Top 10% NationallyRanked #1590
- 2023$5M Cumulative Funding